Levodopa with carbidopa
Co-careldopa
The main medicine for Parkinson's disease, combining levodopa with carbidopa to ease slowness, stiffness and tremor.
What is Co-careldopa?
Co-careldopa combines levodopa, which the brain turns into the chemical messenger dopamine that is lacking in Parkinson's disease, with carbidopa, which helps more of the levodopa reach the brain and reduces sickness. It is the mainstay treatment for Parkinson's and helps with slowness of movement, stiffness and tremor. It should never be stopped suddenly, because doing so can trigger a dangerous reaction. After long-term use, the benefit can start to wear off before the next dose, and extra involuntary movements (dyskinesias) may appear.
Education and reference only. This is a plain-language guide to Co-careldopa — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Co-careldopa is the combination of two medicines, levodopa and carbidopa, used to treat Parkinson's disease. In Parkinson's the brain gradually loses cells that make dopamine, a messenger that helps control movement, leading to slowness, stiffness and tremor. Levodopa is a building block the brain turns into dopamine, while carbidopa stops levodopa being broken down too early in the body so that more reaches the brain and there is less nausea. It is taken by mouth, often several times a day, and is usually the most effective Parkinson's treatment.
How it works
Levodopa crosses into the brain and is converted there into dopamine, replacing some of what has been lost and improving movement. Carbidopa stays mostly outside the brain and blocks the enzyme that would otherwise turn levodopa into dopamine in the body, where it is not wanted and causes sickness. This means a smaller amount of levodopa is needed and side effects such as nausea are reduced. Over time, as the disease progresses, the response can become less smooth.
Company & origin
Originated / developed by: Merck (originator).
A combination of levodopa and carbidopa used in the UK as the mainstay treatment for Parkinson's disease.
What it treats
Conditions Co-careldopa is used for
Practical use
How to take Co-careldopa
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Take it at consistent times each day as prescribed, often several times daily, to keep your movement as steady as possible.
- Try to keep a regular relationship with meals, as protein-rich food can reduce how well it works; your team may suggest taking it before food or spacing protein out.
- Never stop it suddenly or miss several doses, as this can trigger a dangerous reaction; speak to your team before any change.
- Do not be alarmed if your urine or sweat looks darker, as this is a harmless effect of the medicine.
- If you miss a dose, take it when you remember unless it is nearly time for the next, then skip the missed one and do not double up.
Weighing it up
Advantages & disadvantages of Co-careldopa
Advantages
- Usually the most effective treatment for the movement symptoms of Parkinson's disease.
- Carbidopa reduces nausea and lets more levodopa reach the brain.
- Available in regular and longer-acting forms to help smooth out the response.
Disadvantages
- After years of use the benefit can wear off between doses and cause involuntary movements.
- Must never be stopped suddenly because of the risk of a dangerous reaction.
- Effect can be made less reliable by protein-rich meals taken at the wrong time.
Practical use
Good to know
Co-careldopa should never be stopped abruptly, as suddenly stopping can cause a dangerous reaction similar to neuroleptic malignant syndrome, with high fever, severe stiffness and confusion. With long-term use the effect of each dose can wear off before the next is due ("wearing-off"), and some people develop extra involuntary movements called dyskinesias; your specialist team can adjust timing and doses to help. Taking it at consistent times relative to meals matters, because protein in food can compete with levodopa and make it work less reliably. It can darken urine and sweat, which is harmless. Impulse-control problems such as gambling or overspending can occur, though they are more common with dopamine-agonist medicines.
Who should not take it / use with caution
- People with closed-angle glaucoma should not usually take it.
- It is avoided in people with certain skin cancers (melanoma) or undiagnosed suspicious skin lesions.
- It should not be taken with, or close to, certain older antidepressants known as non-selective MAO inhibitors.
Monitoring
- Regular review of movement symptoms, wearing-off and any involuntary movements.
- Watching for confusion, hallucinations and impulse-control changes such as gambling.
- Checking blood pressure, particularly for dizziness on standing up.
Side effects
- Nausea, especially at first, and dizziness on standing are common.
- Involuntary movements (dyskinesias) and wearing-off between doses with long-term use.
- Less commonly, confusion, hallucinations, or impulse-control problems such as gambling.
Key interactions
- Non-selective MAO inhibitor antidepressants must be avoided or carefully separated.
- Some medicines for nausea and certain antipsychotics can block its effect or worsen Parkinson's.
- Iron supplements and high-protein meals can reduce how much is absorbed.
Available as: Tablets taken by mouth, including standard and modified-release forms.
Answers
Co-careldopa: frequently asked questions
Can I stop co-careldopa if I feel better?
No. Stopping suddenly can cause a dangerous reaction with fever, severe stiffness and confusion; any change must be made gradually with your specialist team.
Why does it seem to wear off before my next dose?
After long-term use the effect of each dose can become shorter ("wearing-off"); your team can adjust the timing, dose or form to help smooth this out.
Does food affect it?
Protein-rich meals can compete with the medicine and make it less reliable, so keeping a consistent timing with food, as advised, can help.
Why has my urine gone darker?
Levodopa can darken urine and sweat; this is harmless and does not mean anything is wrong.
Could it cause gambling or overspending?
Impulse-control problems can occur, though they are more common with dopamine-agonist medicines; tell your team about any new urges so it can be reviewed.
The wider class
About Levodopa (Parkinson's)
Co-careldopa belongs to the levodopa (parkinson's) class. For how the class as a whole works, its shared safety principles and monitoring, see the full guide.
Browse by body system
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.